Semaglutide 5mg: What This Dose Actually Means for Wegovy Users

The myth worth correcting: semaglutide 5mg isn't a step on the Wegovy ladder

The most likely reason you landed here is that 5mg appears in searches because it sounds plausible alongside 2.5mg or 7.5mg, strengths that do exist, though for tirzepatide (Mounjaro), not semaglutide. The two medicines work differently, are dosed differently, and should never be used interchangeably. Semaglutide's injection schedule for weight management is 0.25mg, 0.5mg, 1.0mg, 1.7mg, and 2.4mg, escalated roughly monthly by a prescriber. The 7.2mg pen, approved by the MHRA on 14 April 2026, sits at the top as a maximum dose for eligible adults with a BMI of 30 or above. There is no 5mg injection in any part of that sequence.

A separate product sometimes creates confusion here. Rybelsus, the oral semaglutide tablet licensed for type 2 diabetes, comes in 3mg, 7mg, and 14mg. The Wegovy tablet for weight management (approved in the UK on 11 June 2026) uses a completely different strength range: 1.5mg, 4mg, 9mg, and 25mg. Neither schedule has a 5mg entry. If you have seen a product or listing described as "semaglutide 5mg" from a private seller, that is worth treating with caution: where you source Wegovy matters enormously, and anything sold without a proper prescription is a red flag the MHRA has warned about explicitly.

Why semaglutide's doses are lower than you might expect

People sometimes arrive at the dose question expecting weight-loss medicines to follow an intuitive scale, higher weight, higher dose, stronger effect. Semaglutide doesn't work that way. The weekly injection doses are measured in micrograms and low milligrams because the medicine is highly potent at the receptor level. The 0.25mg starting dose isn't a therapeutic plateau; it's a settling-in period. Your digestive system needs a few weeks to adapt before the dose increases. Pushing through that adjustment phase too quickly is the most common reason people experience more nausea than necessary.

According to the NHS medicines page for semaglutide, gastrointestinal effects including nausea, vomiting, and diarrhoea are the most common side effects, and they are most noticeable during dose increases. The slow escalation schedule exists precisely to reduce that burden. A prescriber (not the patient) decides when to increase a dose, based on tolerability and clinical picture. That review happens at every stage, which is why access through a regulated pharmacy with genuine clinical oversight is so different from purchasing a pen without any assessment at all.

Who the licensed semaglutide injection is actually for

Wegovy's UK licence covers adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. NICE's recommendation for semaglutide (TA875) sets a stricter bar for NHS access (it requires a specialist weight management service and limits treatment to two years) but private prescribing follows the licensed criteria rather than those NHS commissioning rules. A fuller picture of how semaglutide works and who it suits is worth reading before deciding anything.

Pregnancy, breastfeeding, and trying to conceive are all situations where semaglutide is not recommended. The medicine is not licensed for anyone under 18. People with a history of medullary thyroid carcinoma, MEN2, or certain pancreatic conditions require careful prescriber discussion before starting. These aren't edge cases, they are part of the clinical assessment every legitimate prescriber carries out. At nume, a GPhC-registered Independent Prescriber personally reviews each consultation the same day, checking your answers, verifying your identity, and confirming your weight on a video call before anything is dispensed. You can verify our pharmacy on the GPhC register (registration 9012878).

Semaglutide on the NHS versus through a private pharmacy

On the NHS, Wegovy is available only through specialist weight management services under NICE TA875, and waiting lists in many areas are long. The phased NHS rollout for tirzepatide (a different medicine) has been expanding through 2025 and 2026, but Wegovy's NHS route remains separate and more restricted. For many people, a private prescription is the practical alternative, and the treatment options at nume include a free consultation, clinical assessment by a named prescriber, and next-working-day delivery once approved. There is no subscription and no automatic renewal; every repeat order goes through clinical review again.

One thing worth knowing about timing: if you're planning around a holiday, a bank holiday, or even just a busy week, ordering by noon on a weekday means same-day dispatch. It's a small practical detail, but when you're mid-titration and need your next pen reliably, it matters. If you have questions before starting, our FAQs cover the most common ones, or you can reach the team directly through our contact page. For those already curious about the earlier steps in the dose schedule, the 0.25mg starter dose page explains what that first pen is actually doing, and if you want to understand more about what semaglutide 2 involves as you progress through the titration, that page covers the next stage in detail. Separately, our guide to the 5 ml semaglutide pen format is worth a look if you are trying to make sense of how vial sizes and doses relate to one another.